
Instil Bio
(NASDAQ) TIL
Instil Bio Financials at a Glance
Market Cap
$54.39M
Revenue (TTM)
$0.00
Net Income (TTM)
-$47.38M
EPS (TTM)
-$7.08
P/E Ratio
-1.13
Dividend
$0.00
Beta (Volatility)
1.67 (High)
Dividend
$0.00
Beta (Volatility)
1.67 (High)
Price
$8.09
Volume
23
Open
$8.08
Price
$8.09
Volume
23
Open
$8.08
Previous Close
$8.09
Daily Range
$8.08 - $8.09
52-Week Range
$5.67 - $41.50
Estimated Earnings Date
Aug 7, 2026
Dividend
$0.00
Beta (Volatility)
1.67 (High)
Price
$8.09
Volume
23
Open
$8.08
Previous Close
$8.09
Daily Range
$8.08 - $8.09
52-Week Range
$5.67 - $41.50
Estimated Earnings Date
Aug 7, 2026
TIL News
TIL: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Instil Bio
Industry
Biotechnology
Sector
Health CareEmployees
17
CEO
Bronson Crouch
Website
www.instilbio.comHeadquarters
Dallas, TX 75219, US
TIL Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-37%
Return on Capital
-28%
Return on Assets
-24%
Earnings Yield
-88.50%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$54.39M
Shares Outstanding
6.78M
Volume
23
Avg. Volume
26.81K
Financials (TTM)
Gross Profit
-$534.00K
Operating Income
-$52.91M
EBITDA
-$52.37M
Operating Cash Flow
-$36.62M
Capital Expenditure
$0.00
Free Cash Flow
-$36.62M
Cash & ST Invst.
$76.13M
Total Debt
$85.18M
Instil Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$12.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$54.39M
N/A
Market Cap/Employee
$3.89M
N/A
Employees
14
N/A
Net Income
-$4.20M
+85.1%
EBITDA
-$6.01M
+77.6%
Quarterly Fundamentals
Net Cash
$74.57M
+339.1%
Accounts Receivable
$7.97M
+762.3%
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
-100.0%
Return on Assets
-23.64%
N/A
Return on Invested Capital
-27.61%
N/A
Free Cash Flow
-$1.34M
+68.1%
Operating Cash Flow
-$1.34M
+68.1%


